IP Verse

Agios Pharmaceuticals competitive analysis

Latest publications and patents of Agios Pharmaceuticals New

Explore the latest publications and patents granted to Agios Pharmaceuticals, showcasing their recent innovations and technological advancements.

Last updated on: Sep 22, 2025
Publication NumberPublication DateTitleLegal Status

Get instant update for new patents of Agios Pharmaceuticals

EP3307271
Sep 13, 2023Methods Of Using Pyruvate Kinase ActivatorsGranted And Under Opposition
EP3713919
Aug 2, 2023Crystalline Forms Of N-(4-(4-(Cyclopropylmethyl) Piperazine-1-Carbonyl)Phenyl)Quinoline-8-SulfonamideGranted And Under Opposition

Latest patents of Agios Pharmaceuticals opposed by its competitors

Explore Agios Pharmaceuticals's recently opposed patents, revealing key competitive challenges and strategic patent disputes in the industry. Track oppositions filed by competitors to understand technology battlegrounds and assess potential risks.

Last updated on: Sep 25, 2025
Patent NumberGrant DateTitleTotal Oppositions
EP3307271
Sep 13, 2023Methods Of Using Pyruvate Kinase Activators2
EP3713919
Aug 2, 2023Crystalline Forms Of N-(4-(4-(Cyclopropylmethyl) Piperazine-1-Carbonyl)Phenyl)Quinoline-8-Sulfonamide2

Latest PTAB cases involving Agios Pharmaceuticals

Discover the latest PTAB cases involving Agios Pharmaceuticals, highlighting their recent legal challenges and patent disputes.

Peer Comparison New

IP litigation analysis comparing Agios Pharmaceuticals with top 3 competitors. Includes complete PTAB case data and opposition data from 2018 onwards.

Last updated on: Sep 25, 2025
CompanyOppositions FiledOppositions FacedPTAB Cases FiledPTAB Cases FacedStrategy Type
AGIOS PHARMACEUTICALS - 4 - - Non-Active
BOTTI & FERRARI13 - - - Highly Aggressive
SANDOZ1141519 - Highly Aggressive